CHRISTINE CZACHOWSKI: Open Payments
NPI 1124319439 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,679 in 57 payments from 25 companies in 2025. Trend: 2023 $1,283 · 2024 $1,231 · 2025 $1,679
Food & beverage: $1,480Education: $199
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $195 |
| ABBVIE INC. | 5 | $194 |
| Incyte Corporation | 3 | $185 |
| Janssen Biotech, Inc. | 3 | $165 |
| AstraZeneca Pharmaceuticals LP | 3 | $139 |
| Stemline Therapeutics Inc. | 2 | $123 |
| Aveo Pharmaceuticals, Inc. | 1 | $99 |
| Celgene Corporation | 4 | $72 |
| Tempus AI, Inc | 1 | $61 |
| Gilead Sciences, Inc. | 3 | $61 |
Products named: ENHERTU, Orserdu, RYBREVANT, CREON, OPDIVO, FOTIVDA, REBLOZYL, XT CDX.
Industry payments across MO — which companies pay providers there.
